Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE) ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1-2 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1-2, 12.2008
- Urheber
-
Absalon, J.
- Beteiligte Personen und Organisationen
-
Thal, G.
Thiry, A.
Yang, R.
Mancini, MD
McGrath, D.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P136
- URN
-
urn:nbn:de:1111-2016052055964
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Absalon, J.
- Thal, G.
- Thiry, A.
- Yang, R.
- Mancini, MD
- McGrath, D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Therapeutic vaccines in HBV: lessons from HCV
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
Hospitalizations and deaths among people coinfected with HIV and HCV
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Therapeutic vaccines in HBV: lessons from HCV
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
Hospitalizations and deaths among people coinfected with HIV and HCV
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Therapeutic vaccines in HBV: lessons from HCV
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
Hospitalizations and deaths among people coinfected with HIV and HCV
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg